GO:0046085 adenosine metabolic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046085 adenosine metabolic process describes all chemical reactions and pathways involving adenosine, the adenine ribonucleoside found as a free nucleoside and within nucleic acids and nucleoside coenzymes.
• Adenosine metabolism is a balance of production (from ATP, SAM, and RNA turnover) and clearance (via adenosine kinase, ADA, and ADAL), and this balance controls methylation, signaling, and cell survival.
• Adenosine kinase (ADK) and ADAL detoxify modified adenosines and safeguard cellular metabolism, linking adenosine clearance to epigenetic and epitranscriptomic regulation.
• Adenosine metabolic clearance maintains liver homeostasis by licensing arginine methylation of RIPK1, connecting adenosine catabolism to inflammatory cell death and tissue integrity.
• Dysregulated adenosine metabolism is implicated in cancer metabolism, epilepsy, neuroblastoma, and metabolic dysfunction-associated steatohepatitis (MASH)-related hepatocellular carcinoma.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of adenosine metabolic enzymes and their roles in disease.
Description
Adenosine is a ribonucleoside that sits at the intersection of energy metabolism, nucleic acid turnover, and cell signaling. GO:0046085, adenosine metabolic process, is the Gene Ontology term that captures the chemical reactions and pathways involving adenosine, including its formation, interconversion, and degradation. Because adenosine is both a building block of RNA and a signaling molecule, its metabolic flux must be tightly controlled to avoid toxic accumulation of modified intermediates and to supply methyl-donor and nucleotide pools. Researchers study this process to understand how cells balance nucleotide supply with epigenetic regulation, and how disruption of this balance contributes to cancer, neurological disease, and liver pathology. The term is therefore central to projects in cancer metabolism, epitranscriptomics, and metabolic liver disease, where adenosine-handling enzymes such as ADK, ADAL, and ADA are increasingly recognized as therapeutic nodes.
adenosine metabolic process At A Glance
| GO ID | GO:0046085 |
|---|---|
| GO term | adenosine metabolic process |
| Ontology | biological_process |
| Synonym | adenosine metabolism |
| Definition | The chemical reactions and pathways involving adenosine, adenine riboside, a ribonucleoside found widely distributed in cells of every type as the free nucleoside and in combination in nucleic acids and various nucleoside coenzymes. |
| Major function | Maintains adenosine and modified-adenosine homeostasis, supports nucleotide salvage, and prevents toxic intermediate accumulation. |
| Key enzymes | Adenosine kinase (ADK), adenosine deaminase (ADA), ADAL, and methyltransferases such as METTL3/METTL14 that generate modified adenosines. |
| Disease links | Cancer metabolism, epilepsy, neuroblastoma, and MASH-related hepatocellular carcinoma. |
| Research methods | CRISPR KO/point-mutation/knock-in models, metabolomics, RNA-seq, and m6A mapping. |
What Is GO:0046085?
In this article, adenosine metabolic process (GO:0046085) refers to the set of biochemical reactions and pathways that produce, modify, and clear adenosine, the adenine ribonucleoside that exists both as a free nucleoside and as a component of nucleic acids and nucleoside coenzymes. The term encompasses enzymatic steps that generate adenosine from nucleotide precursors, reactions that salvage or phosphorylate it, and catabolic routes that remove it or its modified forms to maintain metabolic homeostasis.
Why Is adenosine metabolic process Important in Cell Biology?
Adenosine metabolic process is important because adenosine and its modified derivatives are both essential metabolites and potent regulators of cell state. When adenosine clearance fails, modified adenosines can accumulate and disrupt methylation-dependent processes, while altered adenosine signaling influences neuronal excitability and tumor metabolism. The pathway therefore connects core metabolism to epigenetic control, inflammation, and cell death, making it a high-value area for mechanistic and translational research.
• Controls availability of adenosine for nucleotide salvage and RNA metabolism.
• Prevents accumulation of toxic modified adenosines through ADK and ADAL activity.
• Supports methylation-dependent signaling, including arginine methylation of RIPK1 in liver homeostasis.
• Links to cancer metabolism reprogramming and m6A RNA methylation.
• Modulates neuronal excitability and is implicated in epilepsy.
• Contributes to neuroblastoma biology and diet-responsive metabolic reprogramming.
• Participates in MASH-related hepatocellular carcinoma growth via m6A-dependent mechanisms.
• Provides druggable nodes (ADK, ADA, ADAL) for metabolic and oncologic intervention.
• Serves as a model for studying epitranscriptomic writer and eraser enzymes such as METTL3/METTL14.
• Enables CRISPR-based causal dissection of metabolic versus signaling contributions.
What Happens During adenosine metabolic process?
Adenosine production from nucleotide and methyl-donor turnover
In simple terms: Adenosine is generated when cells break down nucleotides and methyl-donor molecules.
Adenosine arises from the turnover of ATP, S-adenosylmethionine (SAM), and RNA, as well as from salvage of adenine nucleotides. Methylation reactions that use SAM produce S-adenosylhomocysteine (SAH), which is hydrolyzed to homocysteine and adenosine, directly linking methylation flux to adenosine pools. Modified adenosines generated during RNA metabolism also feed into this production stream and must be handled by dedicated enzymes.
Salvage and phosphorylation by adenosine kinase
In simple terms: Adenosine kinase recycles adenosine back into the nucleotide pool.
Adenosine kinase (ADK) phosphorylates adenosine to AMP, allowing it to re-enter the nucleotide pool. This salvage step is a major determinant of intracellular adenosine concentration and prevents adenosine from accumulating to levels that could interfere with methylation and signaling. ADK activity is therefore a central control point in adenosine metabolic process.
Deamination and detoxification of modified adenosines
In simple terms: ADA and ADAL remove or modify adenosine and its altered forms to keep cells safe.
Adenosine deaminase (ADA) converts adenosine to inosine, while ADAL (adenosine deaminase-like) processes modified adenosines. Together with ADK, these enzymes coordinate detoxification of modified adenosines to safeguard metabolism, and loss of this coordination leads to metabolic stress. This step is essential for maintaining the fidelity of methylation-dependent processes.
Adenosine clearance and licensing of methylation-dependent signaling
In simple terms: Clearing adenosine allows methylation reactions that control cell survival to proceed.
Adenosine metabolic clearance maintains liver homeostasis by licensing arginine methylation of RIPK1, a modification that restrains inflammatory cell death. When clearance is impaired, SAH and adenosine accumulate, methylation is inhibited, and RIPK1-dependent pathology can emerge. This illustrates how adenosine catabolism is mechanistically coupled to epigenetic and post-translational regulation.
Integration with m6A RNA methylation and cancer metabolism
In simple terms: Adenosine metabolism intersects with RNA methylation marks that reprogram cancer cells.
The m6A RNA methylation machinery, including METTL3 and METTL14, writes methyl marks on adenosine within RNA, and this process is tightly linked to cancer metabolism. Structural and biochemical studies show that METTL3 and METTL14 function cooperatively to methylate adenosine. In MASH-related hepatocellular carcinoma, m6A-dependent mechanisms involving intranuclear paraspeckle-circular RNA TACC3 assembly promote tumor growth, connecting adenosine modification to oncogenic programs.
Key Genes Involved in GO:0046085 adenosine metabolic process
The following genes and proteins are central to adenosine metabolic process and are frequently studied in mechanistic and translational research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ADK | Phosphorylates adenosine to AMP, controlling intracellular adenosine levels | Target for epilepsy and metabolic studies; KO models reveal adenosine signaling effects |
| ADA | Deaminates adenosine to inosine | Key detoxification enzyme; relevant to immune and metabolic disorders |
| ADAL | Processes modified adenosines and supports detoxification | Linked to safeguarding metabolism and methylation |
| METTL3 | m6A methyltransferase that methylates adenosine in RNA | Central to epitranscriptomics and cancer metabolism |
| METTL14 | Partner of METTL3 in the m6A methyltransferase complex | Structural and functional studies define cooperative methylation |
| RIPK1 | Kinase regulated by arginine methylation downstream of adenosine clearance | Connects adenosine metabolism to liver homeostasis and cell death |
| ADAR | RNA editing enzyme acting on adenosine in RNA | Engineered ADAR-recruiting RNAs improve editing efficiency and fidelity |
| TACC3 | Circular RNA involved in m6A-dependent HCC growth | Links adenosine modification to MASH-related hepatocellular carcinoma |
| MAT1A | Methionine adenosyltransferase producing SAM | SAM supply influences adenosine production via methylation flux |
| GNMT | Glycine N-methyltransferase consuming SAM | Modulates methylation and adenosine balance |
| AHCY | Hydrolyzes SAH to adenosine and homocysteine | Directly generates adenosine from methylation cycle |
| ENT1 (SLC29A1) | Equilibrative nucleoside transporter | Controls adenosine flux across membranes |
| ENT2 (SLC29A2) | Nucleoside transporter | Contributes to adenosine uptake and signaling |
| CD73 (NT5E) | Generates extracellular adenosine from AMP | Relevant to tumor microenvironment and signaling |
| CD39 (ENTPD1) | Hydrolyzes ATP/ADP to AMP, feeding adenosine production | Linked to extracellular adenosine generation |
| PNP | Purine nucleoside phosphorylase acting on inosine and related nucleosides | Purine salvage and adenosine catabolism |
| XDH | Xanthine dehydrogenase/oxidase in purine catabolism | Downstream purine degradation linked to adenosine metabolism |
| ATIC | Bifunctional purine biosynthesis enzyme | Connects de novo purine synthesis to adenosine pools |
How Is adenosine metabolic process Regulated?
Adenosine metabolic process is regulated at multiple levels. Enzyme abundance and activity of ADK, ADA, and ADAL set the balance between adenosine salvage and clearance, and their coordination is required to detoxify modified adenosines. Methylation flux regulates adenosine production because SAM-dependent methylation generates SAH, which is hydrolyzed to adenosine; consequently, perturbations in methylation alter adenosine pools and downstream signaling. In cancer, m6A RNA methylation and metabolic reprogramming further modulate adenosine-related pathways, linking oncogenic signaling to adenosine metabolism. Extracellular adenosine levels are also controlled by transporters and ectoenzymes such as CD39 and CD73, which shape receptor-mediated signaling in the tissue microenvironment.
adenosine metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ADK | Epilepsy and neuronal excitability | Conditional KO or point-mutation models in neurons |
| ADAL | Metabolic stress and detoxification failure | KO and overexpression cell models |
| RIPK1 | Liver homeostasis and inflammatory cell death | Knock-in of methylation-deficient RIPK1 |
| METTL3 | Cancer metabolism and m6A dysregulation | KO and point-mutation cancer cell lines |
| TACC3 | MASH-related hepatocellular carcinoma | Knock-in and overexpression models |
Adenosine metabolism in cancer and m6A-driven tumors
Adenosine metabolic pathways intersect with cancer metabolism through m6A RNA methylation, which modifies adenosine in RNA and influences tumor cell programs. In MASH-related hepatocellular carcinoma, m6A-dependent assembly of intranuclear paraspeckle-circular RNA TACC3 promotes tumor growth, illustrating how adenosine modification can drive oncogenesis. These findings position adenosine-handling enzymes and m6A writers as candidate targets in liver and other cancers.
Adenosine metabolism and liver homeostasis
Adenosine metabolic clearance maintains liver homeostasis by licensing arginine methylation of RIPK1, and disruption of this axis promotes inflammatory cell death and liver pathology. This mechanism links adenosine catabolism to methylation-dependent control of cell survival, providing a rationale for studying ADK, ADA, and ADAL in metabolic liver disease.
Adenosine metabolism in neurological disease
Adenosine is a key modulator of neuronal excitability, and its metabolic enzymes influence seizure susceptibility. The role of adenosine in epilepsy has been extensively reviewed, with ADK and adenosine receptors implicated in seizure control. This makes adenosine metabolic process a relevant area for neurological research and therapeutic development.
Adenosine metabolism in neuroblastoma and metabolic reprogramming
Diet-enhanced polyamine depletion reprograms neuroblastoma, and metabolic pathways including adenosine-related metabolism contribute to this response. These findings highlight how adenosine metabolism can be modulated by nutritional and metabolic interventions in pediatric tumors.
From adenosine metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ADK alter adenosine levels and seizure susceptibility? | ADK knockout or conditional knockout |
| Does ADAL loss cause toxic modified-adenosine accumulation? | ADAL knockout with metabolomics |
| Does adenosine clearance control RIPK1 methylation? | RIPK1 knock-in of methylation-site mutation |
| Does METTL3 catalytic activity drive cancer metabolism? | METTL3 point-mutation (catalytic dead) knock-in |
| Does m6A modification of TACC3 promote HCC growth? | TACC3 overexpression and m6A-site mutation |
| Can engineered ADAR-recruiting RNAs improve editing? | Overexpression of circular ADAR-recruiting RNAs |
How to Study the adenosine metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | Adenosine, inosine, AMP, SAH levels | Pathway activity and detoxification |
| Stable-isotope tracing | Flux through adenosine metabolism | Mechanistic studies of clearance |
| RNA-seq | Transcriptional changes | Cancer and liver disease models |
| MeRIP-seq / m6A mapping | Adenosine methylation sites on RNA | Epitranscriptomic regulation |
| CRISPR KO screening | Gene essentiality in adenosine pathways | Identify metabolic dependencies |
| Western blot / IP | Protein expression and methylation status | RIPK1 methylation and signaling |
| Fluorescent adenosine sensors | Real-time adenosine dynamics | Live-cell imaging |
| ADAR-recruiting RNA editing | Site-specific RNA editing efficiency | Therapeutic editing applications |
Metabolomics and flux analysis
Mass spectrometry-based metabolomics quantifies adenosine, inosine, AMP, SAH, and related metabolites to assess pathway activity. Stable-isotope tracing can reveal flux through adenosine production and clearance routes, which is essential for linking genotype to metabolic phenotype.
RNA-seq and m6A mapping
RNA-seq and m6A-specific mapping (e.g., MeRIP-seq) measure transcript abundance and adenosine methylation marks. These methods are used to determine how METTL3/METTL14 and adenosine metabolism influence gene expression programs in cancer and liver disease.
CRISPR-based genetic perturbation
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of adenosine metabolic enzymes. For example, catalytic-dead METTL3 knock-in distinguishes methylation-dependent from scaffolding functions, while ADK knockout reveals effects on adenosine signaling.
Imaging and reporter assays
Genetically encoded adenosine sensors and fluorescent reporters enable real-time measurement of adenosine dynamics in live cells and tissues. These tools complement biochemical assays and help localize adenosine metabolism to specific cellular compartments.
How CRISPR Can Be Used to Study GO:0046085 adenosine metabolic process
Knockout
CRISPR knockout of ADK, ADA, or ADAL abolishes enzyme activity and reveals consequences for adenosine levels, methylation, and cell survival. Knockout models are used to test whether a gene is required for detoxification of modified adenosines and to identify metabolic vulnerabilities.
Point Mutation
Point mutations that inactivate catalytic residues (e.g., in METTL3 or ADK) allow separation of enzymatic activity from structural or scaffolding roles. Such models are critical for determining whether a phenotype depends on adenosine metabolism per se or on protein-protein interactions.
Knock-in
Knock-in of disease-associated or methylation-site mutations (e.g., RIPK1 arginine-to-lysine) enables precise testing of post-translational regulation downstream of adenosine clearance. Knock-in models provide causal evidence linking adenosine metabolism to specific signaling events.
Overexpression
Overexpression of adenosine metabolic enzymes or modified RNAs (e.g., circular ADAR-recruiting RNAs) tests gain-of-function effects and therapeutic potential. Overexpression models are used to assess whether increasing clearance or editing capacity can rescue metabolic or disease phenotypes.
How EDITGENE Supports adenosine metabolic process Research
Researchers studying adenosine metabolic process-related genes often need to determine whether a candidate gene is causally involved in metabolite flux, methylation-dependent signaling, or disease phenotypes. Rigorous causal inference requires well-controlled genetic models that isolate enzymatic activity, localization, and interaction domains. EDITGENE provides end-to-end CRISPR services to generate such models efficiently and reproducibly.
Contact EDITGENE today to design your custom CRISPR model for adenosine metabolic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| ACP3 Knockout HEK293 Cell Line | EDJ-KQ2521 | Human | 55 | Details Get a Quote |
| BLOC1S6 Knockout HEK293 Cell Line | EDJ-KQ8488 | Human | 26258 | Details Get a Quote |
| NT5C1A Knockout HEK293 Cell Line | EDJ-KQ10135 | Human | 84618 | Details Get a Quote |
| NT5C1B Knockout HEK293 Cell Line | EDJ-KQ11149 | Human | 93034 | Details Get a Quote |
| ADA Knockout HEK293 Cell Line | EDJ-KQ17800 | Human | 100 | Details Get a Quote |
| ADA Knockout A-549 Cell Line | EDJ-KQ22204 | Human | 100 | Details Get a Quote |
| ADA Knockout HCT 116 Cell Line | EDJ-KQ22205 | Human | 100 | Details Get a Quote |
| ADA Knockout HeLa Cell Line | EDJ-KQ22206 | Human | 100 | Details Get a Quote |
| BLOC1S6 Knockout A-549 Cell Line | EDJ-KQ34602 | Human | 26258 | Details Get a Quote |
| BLOC1S6 Knockout HCT 116 Cell Line | EDJ-KQ34603 | Human | 26258 | Details Get a Quote |
| BLOC1S6 Knockout HeLa Cell Line | EDJ-KQ34604 | Human | 26258 | Details Get a Quote |
| ACP3 Knockout HeLa Cell Line | EDJ-KQ52538 | Human | 55 | Details Get a Quote |
| NT5C1A Knockout HeLa Cell Line | EDJ-KQ57616 | Human | 84618 | Details Get a Quote |
| NT5C1B Knockout HeLa Cell Line | EDJ-KQ57852 | Human | 93034 | Details Get a Quote |
| ACP3 Knockout A-549 Cell Line | EDJ-KQ61020 | Human | 55 | Details Get a Quote |
Displaying Records 1 To 15 Of 20 Records
Frequently Asked Questions About adenosine metabolic process
What is adenosine metabolic process (GO:0046085)?
It is the biological process comprising all chemical reactions and pathways involving adenosine, including its production, salvage, and clearance.
What genes are involved in adenosine metabolic process?
Key genes include ADK, ADA, ADAL, METTL3, METTL14, AHCY, and transporters such as SLC29A1, among others.
How is adenosine cleared in cells?
Adenosine is phosphorylated by ADK or deaminated by ADA, and modified adenosines are detoxified by ADAL to maintain metabolic homeostasis.
Why is adenosine metabolism important in cancer?
It intersects with m6A RNA methylation and metabolic reprogramming, influencing tumor growth and therapeutic response.
What is the role of ADK in epilepsy?
ADK regulates adenosine levels that modulate neuronal excitability, and its dysfunction is linked to seizure susceptibility.
How does adenosine metabolism affect liver homeostasis?
Adenosine clearance licenses arginine methylation of RIPK1, and its disruption promotes inflammatory cell death in the liver.
What methods are used to study adenosine metabolic process?
Metabolomics, RNA-seq, m6A mapping, CRISPR perturbation, and fluorescent sensors are commonly used.
Can CRISPR be used to study adenosine metabolism?
Yes, knockout, point-mutation, knock-in, and overexpression models enable causal testing of adenosine metabolic genes.
What is the link between adenosine metabolism and m6A?
m6A is a methylation mark on adenosine in RNA, and its writers METTL3/METTL14 are directly connected to adenosine metabolism and cancer.
What diseases are associated with adenosine metabolic process?
Cancer, epilepsy, neuroblastoma, and MASH-related hepatocellular carcinoma are among the diseases linked to this process.
Conclusion
Adenosine metabolic process (GO:0046085) is a central biological process that balances adenosine production, salvage, and clearance to support nucleotide metabolism, methylation-dependent signaling, and cell survival. Its dysregulation is implicated in cancer, liver disease, epilepsy, and neuroblastoma, making it a rich area for mechanistic and translational research. CRISPR-based models that precisely manipulate ADK, ADA, ADAL, METTL3, and related genes provide the causal evidence needed to advance therapeutic strategies targeting adenosine metabolism.
References
- 1. An Y et al.. 2022. The role of m6A RNA methylation in cancer metabolism.. Mol Cancer 21(1):14 PMID: 35022030
- 2. Liu R et al.. 2026. Adenosine metabolic clearance maintains liver homeostasis by licensing arginine methylation of RIPK1.. J Exp Med 223(1) PMID: 41081715
- 3. Cherkaoui S et al.. 2025. Reprogramming neuroblastoma by diet-enhanced polyamine depletion.. Nature 646(8085):707-715 PMID: 40993392
- 4. Ogawa A et al.. 2025. Adenosine kinase and ADAL coordinate detoxification of modified adenosines to safeguard metabolism.. Cell 188(22):6151-6169.e24 PMID: 40840445
- 5. Wang P et al.. 2016. Structural Basis for Cooperative Function of Mettl3 and Mettl14 Methyltransferases.. Mol Cell 63(2):306-317 PMID: 27373337
- 6. Fu J et al.. 2025. Intranuclear paraspeckle-circular RNA TACC3 assembly forms RNA-DNA hybrids to facilitate MASH-related hepatocellular carcinoma growth in an m(6)A-dependent manner.. Cancer Commun (Lond) 45(11):1583-1610 PMID: 41103024
- 7. Yi Z et al.. 2022. Engineered circular ADAR-recruiting RNAs increase the efficiency and fidelity of RNA editing in vitro and in vivo.. Nat Biotechnol 40(6):946-955 PMID: 35145313
- 8. Weltha L et al.. 2019. The role of adenosine in epilepsy.. Brain Res Bull 151:46-54 PMID: 30468847
